Imugene now in $60m cash call for new deal
MELBOURNE: Imugene was leveraging a new cancer treatment licensing deal yesterday, asking investors for a… read more
Pro Medicus reports $60.6m profit for year ending 2023
SYDNEY: Medical imaging software company Pro Medicus says an acute shortage of radiologists and a… read more
CSL sheds COVID chains as it chases plasma boost
SYDNEY: Australia’s premier biotech CSL has shrugged off doubts it can rebound from pandemic challenges… read more
Cochlear investors hear siren call of big profits
SYDNEY: Hearing device maker Cochlear aims to boost margins and revenue this year, amid plans… read more
